ASX:PXS

Company News / by - 10 years ago

Pharmaxis refused marketing

27 Jun 2011 - The Committee for Medicinal Products for Human Use (CHMP) has told Pharmaxis (ASX:PXS) it can't market its Bronchitol drug in Europe, because the benefit of the drug …